Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-07T04:21:49.274Z Has data issue: false hasContentIssue false
  • English
  • Français

Making the Case for Talking to Patients about the Costs of End-of-Life Care

Published online by Cambridge University Press:  01 January 2021

Greer Donley  and
Marion Danis
Get access Rights & Permissions [Opens in a new window]

Extract

The cost of health care at the end of life accounts for a high proportion of total health care costs in the United States. The percentage of Medicare payments attributable to patients in their last year of life was 28.3% in 1978 and has remained substantially the same at 25.1% in 2006. This indicates how little progress has been made in containing these costs, though doing so will be important to promote a financially sustainable health care system. These expenditures also highlight the prospect that efforts to reduce health care costs overall are likely to disproportionately affect the care patients receive at the end of life.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 39 , Issue 2 , Summer 2011 , pp. 183 - 193
Copyright
Copyright © American Society of Law, Medicine and Ethics 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Riley, G. F.and Lubitz, J. D., “Long Term Trends in Medicare Payments in the Last Year of Llife,” Health Services Research 45, no. 2 (2010): 565–576.CrossRefGoogle Scholar
Meyerson, N. et al., “The Long-Term Outlook for Health Care Spending,” Office, C. B., Editor, 2007.Google Scholar
See Riley, , supra note 1; Hogan, C. et al., “Medicare Beneficiaries' Costs of Care in the Last Year of Life,” Health Affairs 20, no. 4 (2001): 188–195.Google Scholar
Norredam, M. et al., “Financial Status, Employment, and Insurance among Older Cancer Survivors,” Journal of General Internal Medicine 24, no. 2 (2009): 438–435; Weaver, K. E. et al., “Forgoing Medical Care Because of Cost,” Cancer 116, no. 14 (2010): 3493–3504; Langa, K. M. et al., “Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer,” Value in Health 7, no. 2 (2004): 186–194; Blendon, R. J. et al., “Americans’ Views of Health Care Costs, Access, and Quality,” Milbank Quarterly 84, no. 4 (2006): 623–657; Szabo, L. Appleby, J., “21% of Americans Scramble to Pay Medical, Drug Bills,” USA Today, March 3, 2009; Hanratty, B. et al., “Financial Stress and Strain Associated with Terminal Cancer-a Review of the Evidence,” Palliative Medicine 21, no. 7 (2007): 595–607.CrossRefGoogle Scholar
Id. (Blendon, et al.).Google Scholar
See Weaver, et al., supra note 4.Google Scholar
Emanuel, E. J. et al., “Understanding Economic and Other Burdens of Terminal Illness: The Experience of Patients and Their Caregivers,” Annals of Internal Medicine 132, no. 6 (2000): 451–459.CrossRefGoogle Scholar
Id.; McCarthy, E. P. et al., “Dying with Cancer: Patients' Function, Symptoms, and Care Preferences as Death Approaches,” Journal of American Geriatric Society 48, no. 5 (2000): S110-S121; Covinsky, K. et al., “The Impact of Serious Illness on Patients' Families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment,” JAMA 272, no. 23 (1994): 1839–1844.CrossRefGoogle Scholar
See Emanuel, et al., supra note 7.Google Scholar
See Covinsky, et al., supra note 8.Google Scholar
Grunfeld, E. et al., “Family Caregiver Burden: Results of a Longitudinal Study of Breast Cancer Patients and Their Principal Caregivers,” Canadian Medical Association Journal 170, no. 12 (2004): 1795–1801.CrossRefGoogle Scholar
Szabo, L., “Cancer Care Can Sap a Lifetime of Savings,” USA Today, July 25, 2008.Google Scholar
Truog, R. D. et al., “Rationing in the Intensive Care Unit,” Critical Care Medicine 34, no. 4 (2006): 958–963; Hurst, S. A. and Danis, M., “A Framework for Rationing by Clinical Judgment,” Kennedy Institute of Ethics Journal 17, no. 3 (2007): 247–266; Pearson, S. D., “Caring and Cost: The Challenge for Physician Advocacy,” Annals of Internal Medicine 133, no. 2 (2000): 148–153.CrossRefGoogle Scholar
Schroeder, S. A. and Sandy, L. G., “Specialty Distribution of U.S. Physicians – The Invisible Driver of Health Care Costs,” New England Journal of Medicine 328, no. 13 (1993): 961–963.CrossRefGoogle Scholar
See Hurst, , supra note 13.Google Scholar
Orszag, P. R. and Emanuel, E. J., “Health Care Reform and Cost Control,” New England Journal of Medicine 363, no. 7 (2010): 601–603.CrossRefGoogle Scholar
Daniels, N., Just Health Care (Cambridge: Cambridge University Press, 1985); Daniels, N. and Sabin, J. E., Setting Limits Fairly, 2nd ed. (New York: Oxford University Press, 2008).CrossRefGoogle ScholarPubMed
Alexander, G. C., Casalino, L. P., and Meltzer, D. O., “Patient-Physician Communication about Out-of-Pocket Costs,” JAMA 290, no. 7 (2003): 953–958; Piette, J. D., Heisler, M., and Wagner, T. H., “Cost-Related Medication Underuse: Do Patients with Chronic Illnesses Tell Their Doctors?” Archives of Internal Medicine 164, no. 16 (2004): 1749–1755.CrossRefGoogle Scholar
See id. (Alexander, et al.)Google Scholar
Singer, P. A. and Lowy, F. H., “Rationing, Patient Preferences, and Cost of Care at the End of Life,” Archives of Internal Medicine 152, no. 3 (1992): 478–480; Tseng, C.-W. et al., “Patients’ Willingness to Discuss Trade-offs to Lower Their Out-of-Pocket Drug Costs,” Archives of Internal Medicine 170, no. 16 (2010): 1502–1504.CrossRefGoogle Scholar
Nicholas, J., “ASCO Rx for High Drug Costs: Doctors and Patients Need to Talk,” Journal of the National Cancer Institute 101, no. 21 (2009): 1441–1444; Federman, A. D., “Don't Ask, Don't Tell: The Status of Doctor-Patient Communication about Health Care Costs,” Archives of Internal Medicine 164, no. 16 (2004): 1723–1724.CrossRefGoogle Scholar
See Piette, et al., supra note 18; Tseng, et al., supra note 20.Google Scholar
Zuckerman, D. M., Kasl, S. V., and Ostfeld, A. M., “Psychosocial Predictors of Mortality among the Elderly Poor,” American Journal of Epidemiology 119, no. 3 (1984): 410–423; Lantz, P. M. et al., “Socioeconomic Factors, Health Behaviors, and Mortality: Results from a Nationally Representative Prospective Study of US Adults,” JAMA 279, no. 21 (1998): 1703–1708; Berkman, L. F. and Kawachi, I., Social Epidemiology (New York: Oxford University Press, 2000).CrossRefGoogle Scholar
Preamble to the Constitution of the World Health Organization in the International Health Conference, New York, 1946.Google Scholar
Lee, T. H. and Emanuel, E. J., “Tier 4 Drugs and the Fraying of the Social Compact,” New England Journal of Medicine 359, no. 4 (2008): 333–335; Meropol, N. J. et al., “American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care,” Journal of Clinical Oncology 27, no. 23 (2009): 3868–3874.CrossRefGoogle Scholar
See Alexander, et al., supra note 18; Ginsburg, M., Cost-Effectiveness as a Criterion for Medical and Coverage Decisions: Understanding and Responding to Community Perspectives, Sacramento, 2001.Google Scholar
Id. (Ginsburg).Google Scholar
See Piette, , supra note 18; Hardee, J. T., Platt, F. W., and Kasper, I. K., “Discussing Health Care Costs with Patients: An Opportunity for Empathic Communication,” Journal of General Internal Medicine 20, no. 7 (2005): 666–669.Google Scholar
See Ginsburg, , supra note 26.Google Scholar
See Piette, et al., supra note 18.Google Scholar
See Tseng, et al., supra note 20.Google Scholar
Knaus, W. A., Wagner, D. P., and Lynn, J., “Short-Term Mortality Predictions for Critically Ill Hospitalized Adults: Science and Ethics,” Science 254, no. 5030 (1991): 389–394; Knaus, W. A. et al., “The SUPPORT Prognostic Model: Objective Estimates of Survival for Seriously Ill Hospitalized Adults,” Annals of Internal Medicine 122, no. 3 (1995): 191–203.CrossRefGoogle Scholar
See Alexander, et al., supra note 18; Piette, et al., supra note 18; Nelson, A. et al., “Much Cheaper, Almost as Good: Decrementally Cost-effective medical innovation,” Annals of Internal Medicine 151 (2009): 662–667.Google Scholar
Silveira, M. J., Kim, S. Y. H., and Langa, K. M., “Advance Directives and Outcomes of Surrogate Decision Making before Death,” New England Journal of Medicine 362, no. 13 (2010): 1211–1218.CrossRefGoogle Scholar
Emanuel, L. et al., “Advance Care Planning as a Process: Structuring the Discussion in Practice,” Journal of the American Geriatric Society 43, no. 4 (1995): 440–446.CrossRefGoogle Scholar
Russ, A. J. and Kaufman, S. R., “Family Perceptions of Prognosis, Silence, and the ‘Suddenness’ of Death,’” Culture, Medicine and Psychiatry 29, no. 1 (2005): 103–23; Vig, E. K. et al., “Surviving Surrogate Decision-Making: What Helps and Hampers. The Experience of Making Medical Decisions for Others,” Journal of General Internal Medicine 22, no. 9 (2007): 1274–1279.CrossRefGoogle Scholar
Danis, M. et al., “Stability of Choices about Life-Sustaining Treatments,” Annals of Internal Medicine 120, no. 7 (1994): 567–573.CrossRefGoogle Scholar
See Nicholas, , supra note 21.Google Scholar
Pub. L. 111–148, 124 Stat. 119.Google Scholar
See Meropol, et al., supra note 25.Google Scholar
See Singer, and Lowy, , supra note 20; Fries, J. F. et al., “Reducing Health Care Costs by Reducing the Need and Demand for Medical Services,” New England Journal of Medicine 329, no. 5 (1993): 321–325.Google Scholar
See Silveria, et al., supra note 34.Google Scholar
Emanuel, E. J. and Emanuel, L. L., “The Economics of Dying: The Illusion of Cost Savings at the End of Life,” New England Journal of Medicine 330, no. 8 (1994): 540–544.CrossRefGoogle Scholar